Militello John 4

What Happened

• John Militello, Vice President of Finance, Treasurer and Principal Accounting Officer at Rocket Pharmaceuticals (RCKT), reported an open-market sale of 3,726 shares on 2026-02-13 at $3.31 per share, generating proceeds of approximately $12,341. The filing indicates the shares were sold to satisfy tax withholding obligations tied to the vesting of restricted stock units (RSUs).

Key Details

• Transaction date: 2026-02-13; price: $3.31 per share; shares sold: 3,726; proceeds: ~$12,341.
• Filing date (Form 4): 2026-02-18 (reported five days after the transaction); this appears to be later than the standard Form 4 deadline (normally within two business days).
• Footnotes: F1 — holdings include RSUs that convert one-for-one into common stock; F2 — shares were sold to pay tax withholding on RSU vesting (routine tax-withholding sale).
• Shares owned after the transaction: not specified in the provided filing summary.

Context

• This transaction is a routine, tax-related sale following RSU vesting (a common practice to cover withholding) and does not necessarily signal a change in insider sentiment. Sales to cover tax obligations (transaction code F) are distinct from discretionary market sales.